What this study is
Simplified from ClinicalTrials.govTesting a smart lighting system (SmartEnLite) to see whether it improves mood, behaviors, and sleep in nursing home residents with dementia, ages 55 and older. Researchers will compare it to the usual lighting in nursing homes.
Read the original summary from ClinicalTrials.gov
The goal of this clinical trial is to learn if the Smart Environmental Lighting (SmartEnLite) can help improve behaviors and sleep among residents with dementia in nursing homes. The main questions it aims to answer are:
- What is the effect of SmartEnLite on mood and behaviors?
- What is the effect of SmartEnLite on sleep?
- Would the effect of SmartEnLite on sleep affect its effect on mood and behaviors? Researchers will compare the SmartEnLite to the usual light in nursing homes to see if the SmartEnLite works to improve behaviors and sleep in nursing home residents with dementia.
Participants will:
- Participate in the study for 13 weeks with SmartEnLite for 4 weeks and their usual light.
- Wear a sensor for 13 weeks to measure their sleep and light exposure.
- Be observed for mood, behaviors, and reactions to the lights every other week.
What's being tested
- Smart Environmental Light (SmartEnLite)
Intervention · DEVICE
The SmartEnLite is designed to automatically provide bright light during the daytime and dim light at night, aiming to support circadian rhythms.
Study details
- Official title
- SmartEnLite: A Smart Environmental Lighting Intervention to Improve Behaviors and Sleep for Nursing Home Residents Living With Dementia
- Sponsor
- Penn State University
- Conditions
- Alzheimer's Disease and Related Dementias · Alzheimer Disease and Related Dementias
- Enrolling
- 300 people
- Starts
- 2026-12-01
- Est. completion
- 2031-02
- Design
- Single-blind, randomized, crossover
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 55 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Age≥55
- English speaking
- Nursing home residency≥ 4 weeks
- Clinical Diagnosis of Alzheimer's Disease and related dementia
- Presence of agitation, depression, and/or apathy.
You can't join if
- Major mental illness
- Severe vision impairment
- Severe acute or terminal illness
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openPennsylvania State University
University Park, Pennsylvania, United States
Study team
Sponsor
Penn State University
Study ID STUDY00029328
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.